1. Home
  2. SGHT vs LGI Comparison

SGHT vs LGI Comparison

Compare SGHT & LGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • LGI
  • Stock Information
  • Founded
  • SGHT 2011
  • LGI 2004
  • Country
  • SGHT United States
  • LGI United States
  • Employees
  • SGHT N/A
  • LGI N/A
  • Industry
  • SGHT Medical Specialities
  • LGI
  • Sector
  • SGHT Health Care
  • LGI
  • Exchange
  • SGHT Nasdaq
  • LGI Nasdaq
  • Market Cap
  • SGHT 193.2M
  • LGI 224.1M
  • IPO Year
  • SGHT 2021
  • LGI N/A
  • Fundamental
  • Price
  • SGHT $5.24
  • LGI $17.57
  • Analyst Decision
  • SGHT Buy
  • LGI
  • Analyst Count
  • SGHT 8
  • LGI 0
  • Target Price
  • SGHT $4.50
  • LGI N/A
  • AVG Volume (30 Days)
  • SGHT 221.6K
  • LGI 41.1K
  • Earning Date
  • SGHT 11-06-2025
  • LGI 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • LGI 7.10%
  • EPS Growth
  • SGHT N/A
  • LGI N/A
  • EPS
  • SGHT N/A
  • LGI N/A
  • Revenue
  • SGHT $76,303,000.00
  • LGI N/A
  • Revenue This Year
  • SGHT N/A
  • LGI N/A
  • Revenue Next Year
  • SGHT $12.04
  • LGI N/A
  • P/E Ratio
  • SGHT N/A
  • LGI N/A
  • Revenue Growth
  • SGHT N/A
  • LGI N/A
  • 52 Week Low
  • SGHT $2.03
  • LGI $12.66
  • 52 Week High
  • SGHT $5.52
  • LGI $16.68
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 76.45
  • LGI 54.88
  • Support Level
  • SGHT $3.22
  • LGI $17.34
  • Resistance Level
  • SGHT $5.32
  • LGI $17.70
  • Average True Range (ATR)
  • SGHT 0.31
  • LGI 0.29
  • MACD
  • SGHT 0.22
  • LGI 0.04
  • Stochastic Oscillator
  • SGHT 93.93
  • LGI 81.48

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About LGI Lazard Global Total Return and Income Fund

Lazard Global Total Return & Inc Fd Inc is a United States-based diversified, closed-end management investment company. Its investment objective is total return consisting of capital appreciation and income. The fund's portfolio of investments consists of different sector investments such as consumer staples, financials, consumer discretionary, healthcare, materials, sovereign debt and others.

Share on Social Networks: